Related Experiment Video
Updated: May 15, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Helicobacter pylori infection in Neuromyelitis Optica and Multiple Sclerosis
Youming Long1, Cong Gao, Wei Qiu
1Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and Ministry of Education of China, Institute of Neuroscience, and Department of Neurology, Second Affiliated Hospital of GuangZhou Medical University, Guangzhou, People's Republic of China.
Objective:
To determine the Helicobacter pylori infection status in patients with multiple sclerosis (MS) and neuromyelitis optica (NMO) spectrum.
Methods:
H. pylori infection was certified by indirect immunofluorescence assay. Aquaporin-4 (AQP4) antibody was detected by cell-based assay. H. pylori seroprevalence was measured in 118 patients with NMO (n = 52), high-risk NMO (hrNMO, longitudinally extensive transverse myelitis, n = 17 and recurrent optic neuritis, n = 7), MS (n = 42) and healthy controls (n = 27). Logistic regression analysis was used to determine associations between H. pylori infection and NMO and MS.
Results:
H. pylori antibodies were present in 119 serum samples (82.1%, 119/145), with antibody positivity in 90.4% (47/52) of the patients with NMO, 95.8% (23/24) of the patients with hrNMO, 73.8% (31/42) of the patients with MS and 59.3% (16/27) of the controls. NMO spectrum patients had greater positivity for H. pylori than MS patients (p < 0.05) and controls (p < 0.05). The frequency of H. pylori seropositivity did not significantly differ between MS patients and controls (p = 0.726). H. pylori seropositivity was significantly higher in AQP4 antibody-positive patients (54/58, 93.1%; p = 0.038) than in AQP4 antibody-negative patients (48/60, 80%). Logistic regression analysis showed that H. pylori seropositivity was significantly associated with hrNMO [odds ratio (OR) = 9.311, p = 0.005] or hrNMO + NMO (OR = 6.350, p = 0.028).
Conclusion:
H. pylori infection was present in most Chinese patients with NMO and hrNMO, and may be a risk factor for the NMO spectrum.
Insights
Helicobacter pylori infection is common in patients with Neuromyelitis Optica (NMO) spectrum disorders and may be a risk factor. This study investigated H. pylori status in NMO and Multiple Sclerosis (MS) patients.
Area of Science:
- Neuroimmunology
- Infectious Diseases
- Microbiology
Background:
- Neuromyelitis Optica (NMO) spectrum disorders and Multiple Sclerosis (MS) are inflammatory demyelinating diseases of the central nervous system.
- The role of infectious agents, such as Helicobacter pylori (H. pylori), in the pathogenesis of these conditions is under investigation.
Purpose of the Study:
- To investigate the prevalence of H. pylori infection in patients diagnosed with NMO spectrum disorders and MS.
- To explore the potential association between H. pylori seropositivity and these neurological conditions, including the presence of Aquaporin-4 (AQP4) antibodies.
Main Methods:
- H. pylori infection status was determined using an indirect immunofluorescence assay.
- Aquaporin-4 (AQP4) antibody detection was performed via a cell-based assay.
- Seroprevalence of H. pylori was assessed in patients with NMO, high-risk NMO (hrNMO), MS, and healthy controls, followed by logistic regression analysis.
Main Results:
- A high prevalence of H. pylori antibodies was observed across all groups, with seropositivity rates of 90.4% in NMO, 95.8% in hrNMO, 73.8% in MS, and 59.3% in controls.
- NMO spectrum patients exhibited significantly higher H. pylori positivity compared to MS patients and controls (p < 0.05).
- H. pylori seropositivity was significantly associated with hrNMO (OR = 9.311, p = 0.005) and the combined hrNMO + NMO group (OR = 6.350, p = 0.028).
Conclusions:
- Helicobacter pylori infection is highly prevalent in Chinese patients with NMO and hrNMO.
- H. pylori infection may represent a potential risk factor contributing to the development of the NMO spectrum disorders.
Related Concept Videos
Multiple Sclerosis l: Introduction
Gastritis II: Pathophysiology
Myasthenia Gravis ll: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
